NCT07837154 Blood Flow Restriction Training in Knee Arthropathy
| NCT ID | NCT07837154 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yuxiu Ji |
| Condition | Knee Arthroscopic Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2026-09-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Arthrogenic muscle inhibition (AMI) is the key neurophysiological cause of impeding quadriceps activation following anterior cruciate ligament reconstruction (ACLR). Blood flow restriction training (BFRT) may induce neuroplasticity whereas the neurophysiological responses remain uncertain. In this study, we aimed to explore the effects of constant pressure blood flow restriction training (CP-BFRT) on neurophysiological responses and physical function. Patients will receive the same standardized progressive physical rehabilitation for 2 weeks after the surgery and then start the BRFT or sham BRFT intervention for the following 12 weeks.
Eligibility Criteria
Inclusion Criteria: 1. Knee arthroscopy; 2. Age 18-60 years; 3. Ability to provide informed consent; 4. Availability for follow-up assessments; 5. Written informed consent. Exclusion Criteria: 1. Neurological disorders affecting lower extremity function; 2. Vascular disease or coagulopathy; 3. Contralateral knee pathology; 4. Previous knee surgery; 5. inability to comply with rehabilitation protocols; 6. pregnancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07837154 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Knee Arthroscopic Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07837154 currently recruiting?
Yes, NCT07837154 is actively recruiting participants. Contact the research team at 1062111370@qq.com for enrollment information.
Where is the NCT07837154 trial being conducted?
This trial is being conducted at Luzhou, China.
Who is sponsoring the NCT07837154 clinical trial?
NCT07837154 is sponsored by Yuxiu Ji. The trial plans to enroll 56 participants.